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Background: It is incompletely understood how cigarette smoke (CS) exposure affects lung mucosal immune
responses during viral respiratory infections. B cell activating factor belonging to the tumor necrosis factor family (BAFF)
plays an important role in the induction of secretory immunoglobulin A (S-IgA) which is the main effector of the
mucosal immune system. We therefore investigated the effects of CS exposure on BAFF expression and S-IgA responses
in the lung during influenza virus infection.
Methods: Mice were exposed to CS and/or infected with influenza virus. Bronchoalveolar lavage fluid and lung
compartments were analyzed for BAFF expression, influenza-specific S-IgA level and histological changes. Lung B cells
were isolated and the activation-induced cytidine deaminase (Aicda) expression was determined. BEAS-2B cells were
treated with CS extract (CSE), influenza virus, interferon beta or N-acetylcysteine and BAFF expression was measured.
Results: CS inhibited BAFF expression in the lung, particularly after long-term exposure. BAFF and S-IgA levels were
increased during influenza virus infection. Three-month CS exposure prior to influenza virus infection resulted in
reduced BAFF and S-IgA levels in the lung as well as augmented pulmonary inflammation on day 7 after infection. Prior
CS exposure also caused decreased Aicda expression in lung B cells during infection. Neutralization of BAFF in the lung
resulted in reduced S-IgA levels during influenza virus infection. CSE inhibited virus-mediated BAFF induction in a
dose-dependent manner in BEAS-2B cells, while this inhibition of BAFF by CSE was prevented by pretreatment with the
antioxidant N-acetylcysteine.
Conclusions: Our findings indicate that CS may hinder early mucosal IgA responses in the lung during influenza virus
infection through oxidative inhibition of BAFF, which might contribute to the increased incidence and severity of viral
infections in smokers.
Keywords: B cell activating factor belonging to the tumor necrosis factor family (BAFF), Chronic obstructive pulmonary
disease, Cigarette smoking, Immunoglobulin A, InfluenzaBackground
Large epidemiologic studies clearly show that cigarette
smoking is associated with an increased incidence of re-
spiratory infections such as influenza, and clinical observa-
tions also suggest that these infections are more severe
among smokers [1]. Moreover, chronic obstructive pul-
monary disease (COPD), a condition mainly caused by
cigarette smoke (CS) exposure, is associated with periods* Correspondence: wangjianmiao2010@126.com
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unless otherwise stated.of acute exacerbation of symptoms largely due to respira-
tory infections [2]. These findings suggest that CS expos-
ure may affect respiratory tract defense mechanisms
against pathogens.
Respiratory mucosal immune responses are critical for
protecting the lung from potentially harmful effects of in-
fections [3]. Some studies show that CS exposure impacts
many cell types of mucosal immune system including epi-
thelial cells, macrophages, dendritic cells (DCs) and lym-
phocytes [4,5]. Other studies also suggest that the levels of
secretory immunoglobulin A (S-IgA) are reduced in the
bronchoalveolar lavage (BAL) fluid of COPD patients [6].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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affects mucosal immune responses during respiratory
infections.
S-IgA is the main effector of mucosal immune system
and plays an important role in immune protection
against infectious agents through immune exclusion,
intracellular neutralization and antigen excretion [7].
IgA class switching is the process whereby B cells ac-
quire the expression of IgA, which occurs via both T
cell-dependent (TD) and T cell-independent (TI) path-
ways [8]. The TD pathway requires at least 5–7 days to
develop, a delay that could prove fatal in the presence of
mucosal infections [8]. However, IgA can be rapidly pro-
duced through the faster TI pathway involving B cell ac-
tivating factor belonging to the tumor necrosis factor
family (BAFF) [9,10].
BAFF is an important cytokine for B cell survival and
maturation [11], which is expressed by many cell types
including macrophages, DCs and epithelial cells [12]. It
binds to three receptors on B cells including BAFF
receptor (BAFF-R), transmembrane activator and cal-
cium modulator cyclophilin ligand interactor (TACI)
and B cell maturation antigen (BCMA) [12]. Previous
studies demonstrate that BAFF and its homolog, a
proliferation-inducing ligand (APRIL), can induce TI
IgA class switching and activation-induced cytidine
deaminase (Aicda; an enzyme essential for IgA class
switching) expression in B cells [9,13]. Recent studies also
show that BAFF but not APRIL expression is increased
in the airway during respiratory syncytial virus (RSV)
infections [14].
However, BAFF expression and IgA responses in the
lung during viral infections following CS exposure have
not been studied. In the present study, we utilized mur-
ine and cellular models to investigate the effects of CS
exposure on BAFF expression and mucosal IgA re-
sponses during influenza virus infection.
Methods
Animals
C57BL/6 mice were purchased from the animal center
of Tongji Medical College of Huazhong University of
Science and Technology (Wuhan, China). All animal ex-
periments were approved by the Institutional Animal
Care and Use Committee of Tongji Medical College.
CS exposure
Six to 8 weeks old male mice were exposed to room air
(RA) or the smoke from nonfiltered 3R4F research ciga-
rettes (University of Kentucky, Lexington, KY, USA) using
the smoking apparatus as previously described [15]. Mice
received a half cigarette twice a day to allow for acclima-
tion in the first week and received 1 cigarette twice a day
thereafter.Influenza virus infection
Six to 8 weeks old male mice were anesthetized and
1.5 × 103 plaque forming units of A/PR8/34 (H1N1) in-
fluenza virus (Advanced Biotechnologies, Columbia,
MD, USA) was administered via nasal aspiration in 50 μl
of phosphate buffered saline (PBS) using techniques pre-
viously described [16].
BAFF neutralization
For neutralization of BAFF in the lung, mice were anes-
thetized and intranasally administered with 10 μg of re-
combinant mouse BAFF-R Fc fusion protein (BAFF-R-Fc;
R & D, Minneapolis, MN, USA) in 50 μl of PBS 1 day
prior to influenza virus infection, followed by subsequent
administration of the same dose of BAFF-R-Fc on day 1, 3
and 5 after infection. As control, mice were administered
with 10 ug of isotype control (IgG1) or 50 μl of PBS alone
in the same schedule as BAFF-R-Fc delivery.
BAL
Mice were sacrificed and the trachea was cannulated
and perfused with two 0.75 ml aliquots of PBS. The cel-
lular contents and BAL fluid were separated by centrifu-
gation. Total and differential leukocyte counts were
determined and BAL fluid samples were stored at minus
80°C until analyzed.
B cell isolation
Lung single cell suspensions were prepared using the Lung
Dissociation Kit (Miltenyi Biotec, Auburn, CA, USA) ac-
cording to the protocol described previously [17]. Cells
were incubated with mouse B220 MicroBeads (Miltenyi
Biotec) based on the protocol supplied by the manufac-
turer, and then positively selected for mRNA analysis.
Preparation of CS extract
CS extract (CSE) was freshly prepared by bubbling the
smoke from two 3R4F research cigarettes without filter, at a
rate of 1 cigarette/5 min, to a 50 ml conical tube containing
20 ml culture medium. The extract was filtered through a
0.22 μm filter and was regarded as 100% strength CSE.
Cell culture
BEAS-2B cells (human bronchial epithelium; American
Type Culture Collection, Manassas, VA, USA) were cul-
tured in RPMI 1640 medium supplemented with 10% fetal
bovine serum and 1% penicillin/streptomycin in a humidi-
fied incubator under 5% CO2 at 37°C. Experiments were
performed on cells at 80% confluence. Cells were treated
with various concentrations of CSE and/or infected with
influenza virus at a multiplicity of infection (MOI) of 0.5
for 24 hours. In the experiments of interferon beta (IFN-β)
treatment, cells were treated with various concentrations
of recombinant human IFN-β (PBL Assay Science,
Table 1 Primer sequences used for quantitative polymerase chain reaction
Gene Forward primer Reverse primer
BAFF 5′-AAACACTGCCCAACAATTCC-3′ 5′-TTGCGTGAAATCTGTGCATT-3′
BAFF (human) 5′-ACCGCGGGACTGAAAATCT-3′ 5′-CACGCTTATTTCTGCTGTTCTGA-3′
KC 5′-TGCACCCAAACCGAAGTCAT-3′ 5′-TTGTCAGAAGCCAGCGTTCAC-3′
APRIL 5′-TCACAATGGGTCAGGTGGTATC-3′ 5′-TGTAAATGAAAGACACCTGCACTGT-3′




M1 (viral) 5′-AAGACCAATCCTGTCACCTCTGA-3′ 5′-CAAAGCGTCTACGCTGCAGTCC-3′
18S rRNA 5′-CGCGGTTCTATTTTGTTGGTTT-3′ 5′-GCGCCGGTCCAAGAATTT-3′
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CSE and influenza virus at 0.5 MOI for 24 hours. In the ex-
periments of N-acetylcysteine (NAC) treatment, cells were
pretreated with various concentrations of NAC (Sigma-
Aldrich, St. Louis, MO, USA) for 2 hours and then treated
with 5% CSE and influenza virus at 0.5 MOI for 24 hours.Figure 1 Cigarette smoke (CS) induces inflammation but inhibits BAF
for 1 month, 3 months or 6 months. The relative mRNA levels of (A) BAFF
protein levels and (D) the total leukocyte counts in bronchoalveolar lavageEnzyme-linked immunosorbent assay
BAFF protein levels in BAL fluid were quantified using
commercial enzyme-linked immunosorbent assay (ELISA)
kits (R & D) according to the manufacturer’s instructions.
Influenza-specific S-IgA levels in BAL fluid were deter-
mined by ELISA as described previously [18,19]. S-IgAF expression in the lung. Mice were exposed to room air (RA) or CS
and (C) keratinocyte-derived chemokine (KC) in the lung, (B) BAFF
(BAL) fluid are shown (n = 5–10 mice/group). *P < 0.05; **P < 0.01.
Figure 2 Influenza virus induces BAFF expression and mucosal IgA responses in the lung. Mice were infected with influenza virus and
sacrificed on day 1, day 7 and day 14 after infection. (A) The relative mRNA levels of keratinocyte-derived chemokine (KC) in the lung, (B) the total
leukocyte counts, (C) BAFF protein levels and (D) influenza-specific secretory IgA (S-IgA) levels in bronchoalveolar lavage (BAL) fluid are shown
(n = 3–5 mice/group). CTRL, controls; #, not detected; *P < 0.05; **P < 0.01.
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est dilution of sample for which the optical density was at
least twice that of negative controls. Endpoint S-IgA levels
were expressed as reciprocal log2 titers.
Quantitative polymerase chain reaction
Total RNA was isolated from the lung tissues, lung B
cells, and BEAS-2B cells using RNeasy Plus Mini Kit
(Qiagen, Valencia, CA, USA). After synthesis of cDNA,
quantitative polymerase chain reaction (PCR) was per-
formed using SsoAdvanced Universal SYBR Green
Supermix (Bio-Rad, Hercules, CA, USA) and the spe-
cific primers. The primer sequences are listed in Table 1.
The relative mRNA expression was determined using
the 2-ΔΔCt methods with the 18S rRNA as endogenous
control.
Histology and immunohistofluorescence
Lungs were perfused with 20 ml PBS through the right
ventricle and the right main bronchus was ligated. The leftlung was inflated and fixed with 10% formalin for 24 hours.
The lungs were then paraffin embedded. Hematoxylin and
eosin (H & E) staining was performed by standard proto-
cols. For immunohistofluorescence staining, lung sections
were dewaxed, rehydrated and subjected to heat-induced
epitope retrieval. After blocking, sections were incubated
with rat anti-BAFF monoclonal IgM antibody [Buffy 2]
(Abcam, Cambridge, MA, USA) at 4°C overnight. After
washing, sections were incubated with Alexa Fluor 594
goat anti-rat IgM (μ chain) (Life Technologies, Grand
Island, NY, USA) for 1 hour at room temperature in the
dark, and then washed and coverslipped with Vectashield
HardSet Mounting Medium with DAPI (Vector Labora-
tories, Burlingame, CA, USA).
Statistical analysis
All data were expressed as mean (± SEM) values, unless
otherwise noted. The student unpaired two-tailed t test
was performed for all statistical analyses using GraphPad
Prism 6 software (GraphPad, San Diego, CA, USA).
Figure 3 Cigarette smoke (CS) exposure prior to influenza virus infection results in augmented lung inflammation. Mice were exposed to
room air (RA) or CS for 3 months and then infected with influenza virus or vehicle control. They were sacrificed and evaluated on day 7 after infection.
Representative haematoxylin and eosin stained lung sections from (A) RA-exposed mice, (B) CS-exposed mice, (C) RA-exposed mice with influenza
virus infection and (D) CS-exposed mice with influenza virus infection are shown. Scale bar, 100 μm; Original magnification, ×100.
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Results
CS induces inflammation but inhibits BAFF expression in
the lung
To study BAFF expression in the lung during CS expos-
ure, mice were exposed to RA or CS for 1 month,
3 months or 6 months. We found that short-term CS ex-
posure did not alter BAFF expression significantly. How-
ever, BAFF mRNA expression was decreased significantly
in the lung of mice exposed to CS for 6 months compared
with RA-exposed controls (Figure 1A), and BAFF protein
levels were reduced significantly in BAL fluid after
3-month or 6-month CS exposure (Figure 1B). In addition,
the mRNA expression of keratinocyte-derived chemokine
(KC; a mouse homolog of interleukin-8) in the lung and
the total leukocyte counts in BAL fluid were increased sig-
nificantly at all timepoints (Figure 1C and D).
Influenza virus induces BAFF expression and mucosal IgA
responses in the lung
To investigate BAFF expression and mucosal IgA re-
sponses in the lung during influenza virus infection, mice
were infected and sacrificed on day 1, 7 and 14 after infec-
tion. We found that KC in the lung and the total leukocytecounts in BAL fluid were increased during infection, and
both peaked on day 7 and declined significantly on day 14
(Figure 2A and B). BAFF was induced rapidly and highly
by influenza virus, which also reached a peak value on day
7 and declined on day 14 (Figure 2C). The influenza-
specific S-IgA levels in BAL fluid were also increased
markedly on day 7 and 14 (Figure 2D).
CS exposure prior to influenza virus infection results in
reduced BAFF and S-IgA levels as well as augmented lung
inflammation
To study the effects of prior CS exposure on BAFF expres-
sion and mucosal IgA responses in the lung during
influenza virus infection, mice were infected following 3-
month CS exposure and sacrificed on day 7 after infection.
Histological examination showed that influenza caused al-
veolar and airway inflammatory responses characterized
by the infiltration of inflammatory cells such as macro-
phages, neutrophils and lymphocytes, and these responses
were exaggerated in mice with prior CS exposure
(Figure 3). KC expression was also increased significantly
in these mice compared with those only exposed to virus
(Figure 4A). Similar changes were found in the total
leukocyte counts in BAL fluid (Figure 4B). Importantly,
BAFF was reduced significantly in mice with dual expos-
ure of CS and virus compared with mice only exposed to
Figure 4 Cigarette smoke (CS) exposure prior to influenza infection results in reduced BAFF and secretory IgA (S-IgA). Mice were
exposed to room air (RA) or CS for 3 months and then infected with influenza virus or vehicle control. They were sacrificed and evaluated on day 7
after infection. (A) The relative mRNA levels of keratinocyte-derived chemokine (KC) in the lung, (B) the total leukocyte counts, (C) BAFF protein levels
and (D) influenza-specific S-IgA levels in bronchoalveolar lavage (BAL) fluid are shown (n = 5 mice/group). RA + Flu, RA-exposed mice with influenza
virus infection; CS + Flu, CS-exposed mice with influenza virus infection; #, not detected; *P < 0.05.
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showed that BAFF was strongly expressed in macrophages
and bronchial epithelial cells during infection, and was
markedly reduced by the prior CS exposure (Figure 5).
Furthermore, the influenza-specific S-IgA levels were also
reduced significantly in mice with dual exposure
(Figure 4D). In addition, we also measured APRIL mRNA
expression in the lung and found that there were no sig-
nificant differences in APRIL between these two groups
(data no shown).
CS exposure prior to influenza virus infection causes
decreased Aicda expression in lung B cells
To investigate the effects of prior CS exposure on IgA
class switching in lung B cells during influenza virus infec-
tion, mice were infected following 3-month CS exposure
and lung B cells were isolated on day 7. We found that
Aicda (the hallmark of B cells undergoing active classswitching) mRNA expression was significantly decreased
in lung B cells from the infected mice with prior CS
exposure compared with mice only exposed to virus
(Figure 6A), while there were no significant changes in the
mRNA expression of BAFF-R, TACI and BCMA in lung B
cells between these two groups (Figure 6B, C and D).
BAFF neutralization results in reduced IgA responses in
the lung during influenza virus infection
To explore the effect of BAFF inhibition on mucosal IgA
responses in the lung during influenza virus infection,
mice were intranasally administered with BAFF-R-Fc (the
BAFF specific inhibitor) and sacrificed on day 7 after in-
fection. We found that the influenza-specific S-IgA levels
were reduced significantly in the lung of BAFF-R-Fc-
treated mice compared with isotype control-treated mice
(Figure 7A), while KC expression in the lung and total
leukocyte counts in BAL fluid were increased significantly
Figure 5 Cigarette smoke (CS) exposure prior to influenza virus infection results in reduced BAFF expression. Mice were exposed to
room air (RA) or CS for 3 months and then infected with influenza virus or vehicle control. They were sacrificed and evaluated on day 7 after
infection. Representative immunohistofluorescence stained lung sections from (A) RA-exposed mice with influenza virus infection (cells in
bronchial lumen), (B) CS-exposed mice with influenza virus infection (cells in bronchial lumen), (C) RA-exposed mice with influenza virus infection
(bronchial epithelium) and (D) CS-exposed mice with influenza virus infection (bronchial epithelium) are shown (BAFF: red, nuclear stain DAPI:
blue). Original magnification, ×200.
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the Aicda mRNA expression was decreased significantly
in lung B cells from BAFF-neutralized mice (Figure 7D).
Antioxidant NAC prevents the inhibition of
virus-mediated BAFF induction by CSE in bronchial
epithelial cells
To study the possible mechanisms involved in BAFF in-
hibition by CS, BEAS-2B cells were cultured and treated
with CSE and/or influenza virus as an in vitro model. We
found that BAFF was increased significantly after infec-
tion, while the virus-induced BAFF expression was re-
duced by CSE in a dose-dependent manner (Figure 8A).
Previous in vitro studies suggest that airway epithelial cells
produce BAFF by an IFN-β-dependent mechanism [20]
and CSE inhibits virus-induced IFN-β in these cells [21].
To determine whether CSE reduces virus-induced BAFF
via IFN-β inhibition, cells were treated with IFN-β alone
or in the combination with CSE and virus. We found that
BAFF was induced by IFN-β alone in a dose-dependent
manner (Figure 8B), while IFN-β treatment did not rescue
virus-mediated BAFF induction in the presence of CSE
(Figure 8C). However, the inhibition of virus-mediated
BAFF induction by CSE was prevented by the pretreat-
ment with the antioxidant NAC in a dose-dependentmanner (Figure 8D). In addition, we also measured the
viral RNA levels in the influenza virus-treated cells using
quantitative PCR and found that the treatments (CSE,
IFN-β and NAC) did not significantly affect the replication
of influenza virus in these cells (Additional file 1: Figure
S1A, B and C).
Discussion
BAFF has been extensively studied in autoimmune dis-
eases such as systemic lupus erythematosus and rheuma-
toid arthritis [22], while its role in smoking-related
diseases such as COPD is not fully understood. In the
present study, we show that CS not only induces the lung
inflammation, which plays a central role in COPD [23],
but also inhibits BAFF expression in the lung, particularly
after long-term exposure. However, previous studies have
shown that BAFF expression is increased in the lung of
smokers with stable COPD [24,25]. A possible explanation
is the recent asymptomatic infection or colonization
(or low-grade infection) of respiratory tract with certain
bacteria or viruses that may induce BAFF expression. For
instance, previous studies have suggested that RSV RNA
can be detected in many patients with COPD in the stable
state [26]. Although the definite mechanisms for sustained
high level of BAFF remain unknown, this dysregulation of
Figure 6 Cigarette smoke (CS) exposure prior to influenza infection causes decreased Aicda in lung B cells. Mice were exposed to room
air (RA) or CS for 3 months and then infected with influenza virus or vehicle control. Lung B cells were isolated on day 7 after infection. The
relative mRNA levels of (A) Aicda, (B) BAFF receptor (BAFF-R), (C) transmembrane activator and calcium modulator cyclophilin ligand interactor
(TACI) and (D) B cell maturation antigen (BCMA) in lung B cells are shown (n = 5 mice/group). RA + Flu, RA-exposed mice with influenza virus
infection; CS + Flu, CS-exposed mice with influenza virus infection; *P < 0.05.
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COPD.
Previous studies have demonstrated that BAFF knockout
mice exhibit impaired TI antibody responses [11,12], while
transient overexpression of BAFF enhances specific im-
mune responses to bacterial vaccines [27]. Recent studies
have also shown that BAFF is increased in the lung and as-
sociated with the class-switched antiviral IgA antibody re-
sponses during RSV infections [14,28]. Consistent with
these clinical findings, we show that BAFF expression is
induced rapidly and highly in the lung of mice during in-
fluenza virus infection, particularly in the early stage. The
local influenza-specific S-IgA levels are also markedly in-
creased. Moreover, the neutralization of BAFF in the lung
results in reduced S-IgA levels during infection. These re-
sults suggest that BAFF promotes the mucosal S-IgA re-
sponses in the lung during influenza virus infection.
Interestingly, although BAFF expression is increased in
the lung of COPD patients [24,25], the S-IgA levels arereduced in their BAL fluid [6]. Recent studies show that
IgA accumulates in subepithelial areas of COPD airways
due to the impaired transepithelial transport [25,29],
which may help to explain the reduced S-IgA levels in
BAL fluid from patients with COPD.
In the present study, we have found that CS exposure
prior to influenza virus infection results in reduced BAFF
expression and local influenza-specific S-IgA levels in the
lung. Aicda, a key enzyme essential for IgA class switching
and the hallmark of B cells undergoing active class switch-
ing [30,31], is also decreased in lung B cells from the
virus-infected mice with prior CS exposure compared with
those without prior CS exposrue. There are no significant
differences in APRIL expression between these two
groups. Importantly, the neutralization of BAFF in the
lung results in reduced S-IgA levels and Aicda expression
during influenza virus infection. Taken together, although
prior CS exposure does not alter the expression of the
three BAFF receptors on B cells during infection, given
Figure 7 BAFF neutralization results in reduced IgA responses in the lung during influenza virus infection. Mice were intranasally
administered with BAFF-R-Fc, isotype control or PBS and infected with influenza virus. They were sacrificed and evaluated on day 7 after infection. (A)
The influenza-specific secretory IgA (S-IgA) levels in bronchoalveolar lavage (BAL) fluid, (B) the relative mRNA levels of keratinocyte-derived chemokine
(KC) in the lung, (C) the total leukocyte counts in BAL fluid and (D) the relative mRNA levels of Aicda in lung B cells are shown (n = 5 mice/group).
Flu, infected mice with treatment of PBS; Isotype + Flu, infected mice with treatment of isotype control; BAFF-R-Fc + Flu, infected mice with treatment
of BAFF-R-Fc; *P < 0.05.
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and TI IgA class switching in lung B cells in the early stage
of infection, these results suggest that CS may hinder early
mucosal S-IgA responses through BAFF inhibition in the
lung during influenza virus infection.
Previous studies have shown that BAFF can be induced
by viral infections in several cell types including airway
epithelial cells [14]. Here we show that BAFF is strongly
expressed in bronchial epithelial cells during influenza
virus infection, suggesting the important role of bronchial
epithelial cells in the antiviral immune responses. How-
ever, BAFF is markedly reduced in these cells by prior CS
exposure. Similarly, our in vitro studies also show that
CSE inhibits virus-induced BAFF expression in bronchialepithelial cells. Numerous studies have suggested that CS
impairs airway epithelial cell function and oxidative stress
is an important mechanism for this impairment [32,33].
Here we demonstrate that the inhibition of virus-induced
BAFF expression by CSE can be prevented by the antioxi-
dant NAC. These results suggest that CS may inhibit
virus-induced BAFF expression in the lung through oxida-
tive stress.
A number of studies have suggested that CS enhances
virus-induced inflammatory responses in the lung as ob-
served in COPD viral exacerbations [34-36]. In the present
study, we have also found that CS exposure prior to influ-
enza virus infection results in augmented lung inflamma-
tion. However, the underlying mechanisms responsible for
Figure 8 Antioxidant N-acetylcysteine (NAC) prevents the inhibition of virus-mediated BAFF induction by cigarette smoke extract
(CSE). (A) BEAS-2B cells were treated with indicated concentrations of CSE and/or infected with influenza virus at a multiplicity of infection (MOI)
of 0.5 for 24 hours. (B) BEAS-2B cells were treated with indicated concentrations of interferon beta (IFN-β) for 24 hours. (C) BEAS-2B cells were
treated with indicated concentrations of IFN-β in the combination with 5% CSE and influenza virus at 0.5 MOI for 24 hours. (D) BEAS-2B cells were
pretreated with indicated concentrations of N-acetylcysteine (NAC) for 2 hours and then treated with 5% CSE and influenza virus at 0.5 MOI for
24 hours. The relative mRNA levels of BAFF in BEAS-2B cells are shown. CTRL, without influenza virus infection; Flu, with influenza virus infection;
Flu + CSE, with CSE treatment and influenza virus infection; NS, nonsignificant; *P < 0.05; **P < 0.01.
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equately defined.
It has been suggested that S-IgA, in cooperation with
nonspecific innate factors such as mucociliary clearance,
provides an efficient defense against external agents with-
out inducing a potentially deleterious inflammatory re-
sponse [3]. In addition, although S-IgA is classically
known for neutralizing toxins, bacteria and viruses at mu-
cosal surfaces, recent studies have suggested that it also
has a powerful anti-inflammatory effect due to its ability
to interact with DCs through lectin-like receptors [37,38].
This anti-inflammatory effect of S-IgA plays a crucial role
in the physiology and in the prevention of tissue damage
in many inflammatory diseases [38]. In the present study,
we have found that the local mucosal influenza-specific
S-IgA levels are decreased significantly in the lung of
mice with prior CS exposure during influenza virusinfection. These results suggest that the decrease of S-IgA
in the lung may also contribute to the exaggerated
pulmonary inflammation during viral infection following
CS exposure.
In summary, we report that CS inhibits BAFF in the
lung, particularly after long-term exposure; BAFF and
S-IgA levels are increased during influenza virus infection;
CS exposure prior to influenza virus infection results in
reduced BAFF and S-IgA in the lung, decreased Aicda in
lung B cells as well as augmented pulmonary inflamma-
tion on day 7 after infection; BAFF neutralization results
in reduced S-IgA levels and Aicda expression during in-
fection; CSE inhibits virus-mediated BAFF induction in
bronchial epithelial cells in vitro, while this inhibition can
be prevented by the antioxidant NAC. Our findings indi-
cate that CS may hinder early mucosal IgA responses in
the lung during influenza virus infection through oxidative
Wang et al. Respiratory Research  (2015) 16:37 Page 11 of 12inhibition of BAFF, which might contribute to the increased
incidence and severity of viral infections in smokers. We
believe that a comprehensive understanding of how CS
exposure affects lung mucosal immune responses to re-
spiratory infections will provide new insight into develop-
ment and progression of COPD.
Additional file
Additional file 1: Figure S1. The viral RNA levels in influenza
virus-infected BEAS-2B cells with different treatments.
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